Cargando…

Schwere kutane Arzneimittelreaktionen bei Kindern

Severe cutaneous drug reactions also occur in children and range from reactions with blister forming of skin and mucosa to extensive exanthems with altered differential blood count and involvement of internal organs. The first group includes Stevens-Johnson syndrome (SJS) and toxic epidermal necroly...

Descripción completa

Detalles Bibliográficos
Autor principal: Mockenhaupt, Maja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111328/
https://www.ncbi.nlm.nih.gov/pubmed/37143471
http://dx.doi.org/10.1007/s00112-023-01753-3
_version_ 1785027431211466752
author Mockenhaupt, Maja
author_facet Mockenhaupt, Maja
author_sort Mockenhaupt, Maja
collection PubMed
description Severe cutaneous drug reactions also occur in children and range from reactions with blister forming of skin and mucosa to extensive exanthems with altered differential blood count and involvement of internal organs. The first group includes Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which are considered as one disease entity with different degrees of severity and are also referred to as “epidermal” or “epithelial necrolysis” (EN). The group of drug reactions with primarily systemic alterations is represented by a condition known as drug reaction with eosinophilia and systemic symptoms (DRESS). Although EN is generally considered as a drug reaction, a causative agent can only be identified in about 50% of all pediatric cases. Once a clear diagnosis is established, specific treatment measures should be carried out, whereby discontinuation of the causative agent plays a decisive role in drug-induced cases. In order to be able to identify and discontinue the drug responsible, a detailed medication history must be obtained. Certain antiepileptic drugs, sulfonamides and sulfasalazine are among the most frequent triggers of EN and DRESS in children. Supportive therapy including appropriate topical treatment, pain management and ophthalmological consultations are of utmost importance in EN but a short-term immunomodulating treatment with cyclosporine A has been shown to be helpful. In contrast, in DRESS middle to long-term systemic treatment with glucocorticosteroids is recommended.
format Online
Article
Text
id pubmed-10111328
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-101113282023-04-20 Schwere kutane Arzneimittelreaktionen bei Kindern Mockenhaupt, Maja Monatsschr Kinderheilkd Leitthema Severe cutaneous drug reactions also occur in children and range from reactions with blister forming of skin and mucosa to extensive exanthems with altered differential blood count and involvement of internal organs. The first group includes Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which are considered as one disease entity with different degrees of severity and are also referred to as “epidermal” or “epithelial necrolysis” (EN). The group of drug reactions with primarily systemic alterations is represented by a condition known as drug reaction with eosinophilia and systemic symptoms (DRESS). Although EN is generally considered as a drug reaction, a causative agent can only be identified in about 50% of all pediatric cases. Once a clear diagnosis is established, specific treatment measures should be carried out, whereby discontinuation of the causative agent plays a decisive role in drug-induced cases. In order to be able to identify and discontinue the drug responsible, a detailed medication history must be obtained. Certain antiepileptic drugs, sulfonamides and sulfasalazine are among the most frequent triggers of EN and DRESS in children. Supportive therapy including appropriate topical treatment, pain management and ophthalmological consultations are of utmost importance in EN but a short-term immunomodulating treatment with cyclosporine A has been shown to be helpful. In contrast, in DRESS middle to long-term systemic treatment with glucocorticosteroids is recommended. Springer Medizin 2023-04-18 2023 /pmc/articles/PMC10111328/ /pubmed/37143471 http://dx.doi.org/10.1007/s00112-023-01753-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht, welche die Nutzung, Vervielfältigung, Bearbeitung, Verbreitung und Wiedergabe in jeglichem Medium und Format erlaubt, sofern Sie den/die ursprünglichen Autor(en) und die Quelle ordnungsgemäß nennen, einen Link zur Creative Commons Lizenz beifügen und angeben, ob Änderungen vorgenommen wurden. Die in diesem Artikel enthaltenen Bilder und sonstiges Drittmaterial unterliegen ebenfalls der genannten Creative Commons Lizenz, sofern sich aus der Abbildungslegende nichts anderes ergibt. Sofern das betreffende Material nicht unter der genannten Creative Commons Lizenz steht und die betreffende Handlung nicht nach gesetzlichen Vorschriften erlaubt ist, ist für die oben aufgeführten Weiterverwendungen des Materials die Einwilligung des jeweiligen Rechteinhabers einzuholen. Weitere Details zur Lizenz entnehmen Sie bitte der Lizenzinformation auf http://creativecommons.org/licenses/by/4.0/deed.de (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Leitthema
Mockenhaupt, Maja
Schwere kutane Arzneimittelreaktionen bei Kindern
title Schwere kutane Arzneimittelreaktionen bei Kindern
title_full Schwere kutane Arzneimittelreaktionen bei Kindern
title_fullStr Schwere kutane Arzneimittelreaktionen bei Kindern
title_full_unstemmed Schwere kutane Arzneimittelreaktionen bei Kindern
title_short Schwere kutane Arzneimittelreaktionen bei Kindern
title_sort schwere kutane arzneimittelreaktionen bei kindern
topic Leitthema
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111328/
https://www.ncbi.nlm.nih.gov/pubmed/37143471
http://dx.doi.org/10.1007/s00112-023-01753-3
work_keys_str_mv AT mockenhauptmaja schwerekutanearzneimittelreaktionenbeikindern